MedPath

Changes in Plasma Osmolality Related to the Use of Cardiopulmonary Bypass With Hyperosmolar Prime.

Completed
Conditions
Cardiopulmonary Bypass
Interventions
Other: Blood sampling
Registration Number
NCT03060824
Lead Sponsor
Umeå University
Brief Summary

During the use of Cardiopulmonary Bypass (CPB) for cardiac surgery there is an instant mixture of the patient's blood and the fluid needed to fill the extracorporeal circuit before use. This will change the composition of the body fluids. This study aims to plot these changes in regard to particle concentration (osmolality).

Detailed Description

During the use of CPB for cardiac surgery there is an instant mixture of the patient's blood and the fluid needed to prime the extracorporeal circuit. Many studies have pointed to the benefits of using a hyperosmolar prime to counteract formation of tissue oedema. Rapid changes in osmolality may as a serious consequence lead to osmotic demyelination syndrome. At the Heart Centre of Umeå University Hospital, Sweden, there is a tradition of using a hyperosmolar prime. This study aims to explore changes in osmolality during coronary artery bypass grafting surgery by repeated measurements of osmolality and concentration shifts of sodium, glucose and urea in plasma.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Age 60-80 yr
  • New York Heart Association Functional Classification(NYHA) I-III
  • Body Surface Area(BSA) 1.8-2.5 m2
Exclusion Criteria
  • Diabetes
  • Estimated Glomerular Filtration Rate(eGFR)<50ml/min/1,73 m2

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CABG with the aid of CPB.Blood samplingCardiac surgical patients subjected to coronary artery bypass grafting with the aid of Cardiopulmonary Bypass. Perioperative measurements of osmolality in plasma.
Primary Outcome Measures
NameTimeMethod
Changes in plasma osmolalityBefore surgery; repeated during surgery and on postoperative day 1 and 2.

Repeated measurements of plasma osmolality aim to outline changes in plasma osmolality related to the use of hyperosmolar prime.

Secondary Outcome Measures
NameTimeMethod
Change in osmolar gapBefore surgery; repeated during surgery and on postoperative day 1 and 2.

Analysing urea, sodium and glucose in plasma using the same sampling intervals as for plasma osmolality enables calculation of the osmolar gap and to set its relation to the use of hyperosmolar prime

Trial Locations

Locations (1)

Heart Centre, Umeå University Hospital

🇸🇪

Umeå, Sweden

© Copyright 2025. All Rights Reserved by MedPath